Tumor-associated Macrophage
Reprogramming TAMs toward M1-like macrophages would thus be an efficient way to promote tumor regression. Integrating state-of-the-art Macrophage Therapeutics Development Platform as well as industry-leading expertise in TAM reprogramming, Creative Biolabs is committed to providing overall solutions, focusing on innovative research. Our scientists are fully competent and dedicated to helping our clients’ research and project development.
